Sennazon Syrup recalled over manufacturing violations
- Recall date
- August 8, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharmatech LLC recalls Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, N…
- Recall number
- D-1520-2016
- FDA classification
- Class II
- Brand / firm
- Pharmatech LLC
- Sold / distributed
- Nationwide
Why it was recalled
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.
Get recall alerts
Free email alert whenever Pharmatech LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmatech LLC